Quinolone-binding pocket of DNA gyrase: Role of GyrB

被引:90
作者
Heddle, J [1 ]
Maxwell, A [1 ]
机构
[1] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England
基金
英国生物技术与生命科学研究理事会;
关键词
D O I
10.1128/AAC.46.6.1805-1815.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
DNA gyrase is a prokaryotic type 11 topoisomerase and a major target of quinolone antibacterials. The majority of mutations conferring resistance to quinolones arise within the quinolone resistance-determining region of GyrA close to the active site (Tyr(122)) where DNA is bound and cleaved. However, some quinolone resistance mutations are known to exist in GyrB. Present structural data suggest that these residues lie a considerable distance from the quinolone resistance-determining region, and it is not obvious how they affect quinolone action. We have made and purified two such mutant proteins, GyrB(Asp(426)-->Asn) and GyrB(Lys(447)-->Glu), and characterized them in vitro. We found that the two proteins behave similarly to GyrA quinolone-resistant proteins. We showed that the mutations exert their effect by decreasing the amount of quinolone bound to a gyrase-DNA complex. We suggest that the GyrB residues form part of a quinolone-binding pocket that includes DNA and the quinolone resistance-determining region in GyrA and that large conformational changes during the catalytic cycle of the enzyme allow these regions to come into close proximity.
引用
收藏
页码:1805 / 1815
页数:11
相关论文
共 48 条
[1]   THE 43-KILODALTON N-TERMINAL FRAGMENT OF THE DNA GYRASE-B PROTEIN HYDROLYZES ATP AND BINDS COUMARIN DRUGS [J].
ALI, JA ;
JACKSON, AP ;
HOWELLS, AJ ;
MAXWELL, A .
BIOCHEMISTRY, 1993, 32 (10) :2717-2724
[2]   Toprim - a conserved catalytic domain in type IA and II topoisomerases, DnaG-type primases, OLD family nucleases and RecR proteins [J].
Aravind, L ;
Leipe, DD ;
Koonin, EV .
NUCLEIC ACIDS RESEARCH, 1998, 26 (18) :4205-4213
[3]   Interaction between DNA gyrase and quinolones:: Effects of alanine mutations at GyrA subunit residues Ser83 and Asp87 [J].
Barnard, FM ;
Maxwell, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (07) :1994-2000
[4]  
BARRETT JF, 1990, ANTIMICROB AGENTS CH, V34, P1
[5]   Structure and mechanism of DNA topoisomerase II [J].
Berger, JM ;
Gamblin, SJ ;
Harrison, SC ;
Wang, JC .
NATURE, 1996, 379 (6562) :225-232
[6]   Crystal structure of the breakage-reunion domain of DNA gyrase [J].
Cabral, JHM ;
Jackson, AP ;
Smith, CV ;
Shikotra, N ;
Maxwell, A ;
Liddington, RC .
NATURE, 1997, 388 (6645) :903-906
[7]   DNA topoisomerases: Structure, function, and mechanism [J].
Champoux, JJ .
ANNUAL REVIEW OF BIOCHEMISTRY, 2001, 70 :369-413
[8]   DNA gyrase can cleave short DNA fragments in the presence of quinolone drugs [J].
Cove, ME ;
Tingey, AP ;
Maxwell, A .
NUCLEIC ACIDS RESEARCH, 1997, 25 (14) :2716-2722
[9]   DNA cleavage is not required for the binding of quinolone drugs to the DNA Gyrase - DNA complex [J].
Critchlow, SE ;
Maxwell, A .
BIOCHEMISTRY, 1996, 35 (23) :7387-7393
[10]   CLONING AND CHARACTERIZATION OF A DNA GYRASE-A GENE FROM ESCHERICHIA-COLI THAT CONFERS CLINICAL RESISTANCE TO 4-QUINOLONES [J].
CULLEN, ME ;
WYKE, AW ;
KURODA, R ;
FISHER, LM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (06) :886-894